Antifungal and anti-biofilm activity of designed derivatives from kyotorphin

dc.contributor.authorAndrade, Vitor Martins de
dc.contributor.authorBardaji, Eduard
dc.contributor.authorHeras, Montserrat
dc.contributor.authorRamu, Vasanthakumar G.
dc.contributor.authorJunqueira, Juliana Campos [UNESP]
dc.contributor.authorSantos, Jessica Diane dos [UNESP]
dc.contributor.authorCastanho, Miguel A. R. B.
dc.contributor.authorConceicao, Katia
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniv Girona
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniv Lisbon
dc.date.accessioned2020-12-10T19:58:54Z
dc.date.available2020-12-10T19:58:54Z
dc.date.issued2020-05-01
dc.description.abstractKyotorphin (KTP, L-tyrosyl-L-arginine) is an endogenous analgesic neuropeptide first isolated from bovine brain in 1979. Previous studies have shown that kyotorphins possess anti-inflammatory and antimicrobial activity. Six kyotorphins-KTP-NH2, KTP-NH2-DL, ibuprofen-conjugated KTP (IbKTP), IbKTP-NH2, N-methyl-D-Tyr-L-Arg, and N-methyl-L-Tyr-D-Arg-were designed and synthesized to improve lipophilicity and resistance to enzymatic degradation. This study assessed the antimicrobial and antibiofllm activity of these peptides. The antifungal activity of kyotorphins was determined in representative strains of Candida species, including Candida albicans ATCC 10231, Candida krusei ATCC 6258, and six clinical isolates-Candida dubliniensis 19-S, Candida glabrata 217-S, Candida lusitaniae 14-S, Candida novergensis 51-S, Candida parapsilosis 63, and Candida tropicalis 140-S-obtained from the oral cavity of HIV-positive patients. The peptides were synthesized by standard solution or solid-phase synthesis, purified by RP-HPLC (purity >95 %), and characterized by nuclear magnetic resonance. The results of the broth microdilution assay and scanning electron microscopy showed that IbKTP-NH2 presented significant antifungal activity against Candida strains and antibiofllm activity against the clinical isolates. The absence of toxic activity and survival after infection was assessed after injecting the peptide in larvae of Galleria mellonella as experimental infection model. Furthermore, IbKTP-NH2 had strong antimicrobial activity against multidrug-resistant bacteria and fungi and was not toxic to G. mellonella larvae up to a concentration of 500 mM. These results suggest that IbKTP-NH2, in addition to its known effect on cell membranes, can elicit a cellular immune response and, therefore, is promising for biomedical application. (C) 2019 British Mycological Society. Published by Elsevier Ltd. All rights reserved.en
dc.description.affiliationUniv Fed Sao Paulo, Lab Bioquim Peptideos, Sao Jose Dos Campos, Brazil
dc.description.affiliationUniv Girona, Dept Quim, Lab Innovacio Proc & Prod Sintesi Organ LIPPSO, Girona, Spain
dc.description.affiliationUniv Estadual Paulista, Dept Biociencias & Diagnost Bucal, Inst Ciencia & Tecnol, Sao Jose Dos Campos, Brazil
dc.description.affiliationUniv Lisbon, Inst Med Mol, Fac Med, Lisbon, Portugal
dc.description.affiliationUnespUniv Estadual Paulista, Dept Biociencias & Diagnost Bucal, Inst Ciencia & Tecnol, Sao Jose Dos Campos, Brazil
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipIdFAPESP: 2017/00032-0
dc.description.sponsorshipIdFAPESP: 2018/20571-6
dc.description.sponsorshipIdCAPES: 88881.289327/2018-01
dc.format.extent316-326
dc.identifierhttp://dx.doi.org/10.1016/j.funbio.2019.12.002
dc.identifier.citationFungal Biology. Oxford: Elsevier Sci Ltd, v. 124, n. 5, p. 316-326, 2020.
dc.identifier.doi10.1016/j.funbio.2019.12.002
dc.identifier.issn1878-6146
dc.identifier.urihttp://hdl.handle.net/11449/196874
dc.identifier.wosWOS:000532395600009
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofFungal Biology
dc.sourceWeb of Science
dc.subjectAnalgesic peptide
dc.subjectAntibiofilm
dc.subjectAntimicrobial peptides
dc.subjectToxicity
dc.titleAntifungal and anti-biofilm activity of designed derivatives from kyotorphinen
dc.typeArtigo
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
unesp.author.orcid0000-0003-4506-4553[8]

Arquivos